Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/14/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Richard L. Sherman

Wrong Richard L. Sherman?

Vice President, Business Developm...

Phone: (808) ***-****  HQ Phone
Email: r***@***.com
Hawaii Biotech , Inc.
99-193 Aiea Heights Drive Suite 200
Aiea , Hawaii 96701
United States

Company Description: Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • JD
  • Juris Doctor
    New York University School of Law
  • J.D.
  • B.A. , political science and economics
    University of Nebraska
  • Juris Doctor degree
    New York University School of Law
102 Total References
Web References
SCP Partners
www.scppartners.com, 14 May 2015 [cached]
Richard L. Sherman SCP Partners
The SCP Team
Richard L. Sherman Dick Sherman is a Venture Partner with SCP focusing on the life sciences area.
Prior to joining SCP, he spent more than a decade (1976-1989) as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline) and was founder and managing officer (1992-2001) of QED Technologies, Inc., a life science business consulting firm that is now a wholly-owned subsidiary of The Omnicom Group in New York.
Dick has served on the Board of Directors of CytoMed, Inc., IBAH, Inc., Kenna Technologies, Inc., Mera Pharmaceuticals, Inc., and Sparta Pharmaceuticals.
He also serves as Secretary and General Counsel of Hawaii Biotech, Inc., acts as a consultant to the law firm of Goodsill Anderson Quinn & Stifel, in Honolulu, and is a principal in CIP Capital, L.P.
Dick is involved in a broad range of life sciences industry activities.
He is a Venture Partner of Ventana Global, a venture fund located in Irvine, California, serves as Chairman of Directors at Biophage, Inc., and is a board member of the Sbarro Research Organization.
He is also on the Technology Advisory Board for The Children's Hospital of Philadelphia and is a member of the Advisory Board of the University of Hawaii Medical School.
Dick graduated magna cum laude from the University of Nebraska (1968), where he was elected to Phi Beta Kappa.
He received his J.D. from New York University School of Law in 1971 as a Root-Tilden Scholar.
...
Richard L. Sherman
Hawaii Biotech: About Us: Management
www.hibiotech.com, 10 April 2015 [cached]
Richard Sherman
...
Richard L. Sherman, J.D. Vice President, Business Development and General Counsel
Mr. Sherman has twenty-five years of experience as a licensing executive, attorney, consultant, and venture capitalist in the biotechnology and pharmaceutical industries. As a licensing executive and Deputy General Counsel in a thirteen year career at SmithKline-Beckman Corporation, Mr. Sherman participated as counsel and negotiator in hundreds of international and domestic transactions; including hostile and friendly acquisitions, divestitures, joint ventures, limited partnerships, research and development collaborations, venture capital investments, joint marketing relationships, distribution arrangements, and licensing transactions. Mr. Sherman also founded QED Technologies, Inc., a consulting firm that provides science-based companies with experienced advice and counsel in developing and implementing strategies to maximize their business and technology assets.
Immunomedics - Company Bios
www.immunomedics.com, 14 May 2015 [cached]
Richard L. Sherman is Senior Vice President, Strategic Transactions and General Counsel of TetraLogic Pharmaceuticals Corporation, a privately held biopharmaceutical company that focuses on the discovery and development of SMAC mimetics, small molecule peptide-mimetic drugs that mimic SMAC (second mitochondrial-derived activator of caspases), for the treatment of cancers and certain other diseases. Mr. Sherman also serves as a consultant to the law firm of Goodsill Anderson Quinn & Stifel. Prior to joining TetraLogic in 2012, Mr. Sherman provided consulting services to TetraLogic as Vice President, Strategic Partnering and Transactions at Malvern Consulting Group. From 1976 through 1989, Mr. Sherman served as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline). From 1990 through 1992, he was a partner in the law firm of Pepper Hamilton LLP. In addition, from 1992 through 2001, Mr. Sherman was founder and managing officer of QED Technologies, Inc., a life science business consulting firm purchased in 1999 by The Omnicom Group. Mr. Sherman is also a principal in a private SBIC Investment fund, CIP Capital, L.P., and a venture partner in the SCP/Vitalife family of funds in suburban Philadelphia. Mr. Sherman is currently a member of the Board of Directors of Hawaii Biotech, Inc, a privately held company that develops prophylactic vaccines for infectious diseases.
Richard Sherman, Esq. - ...
www.alohamedicalmission.org, 5 Jan 2014 [cached]
Richard Sherman, Esq. - Secretary
...
Richard Sherman, Esq. Vice-President of Business Development and General Counsel, Hawai'i Biotech Inc.
Dick Sherman is an attorney, entrepreneur and investor who has been active in health-related industries for nearly 40 years. He joined the Aloha Medical Mission Board of Directors in February 2010.
His nonprofit and charitable activities have included services on the boards of the Pennsylvania Biotechnology Association, the Delaware Valley Chapter of the American Corporate Counsel Association (where he also served as president of the chapter), the American Music Theater Festival (also serving as president), The Sbarro Health Research Organization, the Hawai'i Venture Capital Association, and the Hawai'i Science and Technology Council. He has also served as a member of the investment advisory committee of the Ben Franklin Technology Center, the Executive Board of the START Technology Partnership (a consortium of universities), The Technology Advisory Board for Children's Hospital of Philadelphia, and the Advisory Board of the University of Hawai'i John A. Burns School of Medicine. He has participated actively in capital campaigns for a number of organizations, including Kaua'i Hospice, the American Cancer Society and Boy Scouts of America. He has participated in multiple overseas medical missions, including to Vietnam and Bhutan.
Mr. Sherman is the Vice President of Business Development, Secretary and General Counsel of Hawai'i Biotech Inc. (a company developing vaccines for infectious diseases), and serves as a consultant to the law firm of Goodsill Anderson Quinn & Stifel, in Honolulu. He spent more than a decade (1976-1989) as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline), was a partner in the Philadelphia law firm of Pepper Hamilton LLP (1989-1992), and was founder and managing officer (1992-2001) of QED Technologies, Inc., a life-science business consulting firm purchased in 1999 by The Omnicom Group. He maintains an independent consulting practice in the life sciences industry, and is a principal in a private SBIC Investment fund, CIP Capital, L.P. in Philadelphia, Pennsylvania, as well as a Venture Partner of SCP Private Equity Partners and of Vitalife II, venture funds located in suburban Philadelphia. He has also served on the board of directors of a number of for-profit companies.
Mr. Sherman graduated magna cum laude from the University of Nebraska (1968), where he was elected to Phi Beta Kappa. As a Root-Tilden Scholar at the New York University School of Law, he received his Juris Doctor in 1971.
TetraLogic | Management Team
www.tetralogicpharma.com, 22 Mar 2014 [cached]
Richard L. Sherman, J.D. Board of Directors
...
Richard L. Sherman, J.D.
Senior Vice President, Strategic Transactions and General Counsel
Mr. Sherman joined TetraLogic Pharmaceuticals in 2012 and previously provided consulting services to TetraLogic as Vice President, Strategic Partnering and Transactions at Malvern Consulting Group. He spent more than a decade (1976-1989) as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline), was a partner in the law firm of Pepper Hamilton LLP (1990-1992), and was founder and managing officer (1992-2001) of QED Technologies, Inc., a life science business consulting firm purchased in 1999 by The Omnicom Group in New York. He is a principal in a private SBIC Investment fund, CIP Capital, L.P. and a venture partner in the SCP/Vitalife family of funds in suburban Philadelphia. Mr. Sherman has served on the Board of Directors of a number of for-profit companies, including Biophage, Inc., CytoMed, Inc., IBAH, Inc., Kenna Technologies, Inc., Mera Pharmaceuticals, Inc., and Sparta Pharmaceuticals. He is currently a member of the Board of Directors of Functional Technologies Corp., a Vancouver based publicly traded company, Hawaii Biotech, Inc. and Leversense LLC. Mr. Sherman graduated magna cum laude from the University of Nebraska (1968), where he was elected to Phi Beta Kappa. As a Root-Tilden Scholar at the New York University School of Law, he received his Juris Doctor in 1971.
Other People with the name "Sherman":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304